BMAL1 and hepatocellular carcinoma: In several cancers, including HCC [26,27], pancreatic cancer [28,29], and tongue squamous cell carcinoma [30], low expression of BMAL1 has been associated with poor prognosis, suggesting that BMAL1 functions as a tumor suppressor and that increasing its expression may be a potential anti-cancer strategy.